Anthropic says Claude now drives 26% of its own R&D as it weighs a launch before IPO

Anthropic disclosed a striking internal metric: Claude now leads 26% of the company's research and development, up from under 1% in February, orchestrated by roughly 30,000 AI agents. It's a concrete data point in the recursive-self-improvement debate — a frontier lab quantifying how much of its own progress is now AI-driven.

The context sharpens the story. Sources say Anthropic is evaluating a new model release to counter the momentum of OpenAI's GPT-6 Astra, timed ahead of an expected IPO. That ambition sits awkwardly against CEO Dario Amodei's September 12 public call for the industry to slow down — a contradiction critics and the r/Anthropic community were quick to highlight, especially amid reporting that OpenAI and Anthropic 'oversold' recent security breaches to pressure regulators (a thread that drew 336 upvotes).

On safety, Anthropic announced a partnership with Accenture to build embedded evaluators for red-teaming and continuous safety assessment, productizing the kind of external testing that Opus 5.5 also went through pre-release.

Competitively, the 26%-of-R&D figure is both a flex and a liability: it signals Anthropic's efficiency and internal AI leverage, but feeds the exact fears Amodei says he wants to temper. For an IPO narrative, demonstrating that Claude compounds Anthropic's own productivity is a powerful pitch to investors — but it also invites scrutiny over whether the safety-first brand can coexist with an accelerationist reality. What to watch: whether the mooted new model actually ships before any IPO filing, and how regulators respond to labs simultaneously warning of danger and racing to launch.